Home News Japan’s Fujifilm Seeks Approval for Avigan as Treatment for COVID-19

Japan’s Fujifilm Seeks Approval for Avigan as Treatment for COVID-19

Japan’s Fujifilm Seeks Approval for Avigan as Treatment for COVID-19

Fujifilm Holdings Corp 4901.T said on Friday it was seeking to have its flu drug Avigan approved in Japan as a treatment for COVID-19 – a move that comes after a late-stage study showed reduced recovery times for patients with non-severe symptoms.

Shares in Fujifilm rose 3% on the news.

The Nikkei newspaper last month cited here ministry sources as saying approval could be granted within a month of the request being made.

Avigan, known generically as favipiravir, is approved in Japan as an emergency flu medicine. It is the subject of at least 16 clinical trials around the world but concerns remain about the drug as it has been shown to cause birth defects in animal studies.

The government has called on Fujifilm to triple national stockpiles of the drug. The company said in a statement it has been working with strategic partners to meet that goal and requests by other countries to supply the drug.

Fujifilm sold its global rights to Avigan to India’s Dr Reddy’s Laboratories REDY.NS earlier this year. It has been approved to treat COVID-19 in India and Russia.

Last month Fujifilm said the late-stage study of 156 COVID-19 patients in Japan showed that those treated with Avigan improved after 11.9 days, versus 14.7 days for a placebo group. Results of the study, conducted by subsidiary Fujifilm Toyama Chemical, were found to be statistically significant.

 

Eskalera, a Startup Led by Goldman Sachs’ Former HR Head Has Launched a Diversity and Inclusion Index

Eskalera, a technology startup led by Goldman Sachs former human resources head Dane Holmes, has launched an index to measure corporate diversity and inclusiveness,...

HSBC to Remove 35,000 Jobs Amidst Covid-19 Crises

HSBC Holdings Plc has restarted cutting as many as 35,000 jobs, three months after the coronavirus outbreak forced it to pause a long-awaited overhaul...

Genpact Offers Its Internal Skill Training Program Globally for Everyone

Genpact has announced Adapt and Rise, a role-based online learning platform that leverages Genpact's expertise honed from delivering real-world change for hundreds of clients....

San-Francisco Based Learning Platform Degreed Has Raised $32 Million in New Funding

The upskilling platform, Degreed, has announced $32 million in new funding in direct response to overwhelming demand for better skill insights, talent mobility, and...

Research Shows the Implications of Workplace Layouts on Employee Productivity and Overall Performance

As some workplaces prepare for the gradual return of employees and overhaul office layouts and seating plans, research has shown this could also have...

Employee Concierge ‘Back Technologies’ Integrates Automation Into Internal HR and Other Support Tasks

Companies are under increasing pressure to automate workflows and digitally service their employees, particularly in light of trends toward remote work. It takes an...

HR Strategies to Help Your Business Navigate the New ‘Normal’

No business is immune to the massive changes resulting from the health crisis. Organizations have proven themselves to be agile, and employees have demonstrated...

The Importance Of Diversity And Inclusion In HR, Hiring, Talent Management: Thoughts From A Top Expert

Michael C. Hyter is one of today’s best-known experts on inclusion and diversity and the author of The Power of Choice: Embracing Efficacy to Drive Your Career and The...

HR Expert Highlights Actionable Steps to ‘Make Real Change’ Against Racism in Your Workplace

Kyra Leigh Sutton, Ph.D., is a faculty member at the Rutgers University School of Management and Labor Relations, where she teaches human resources courses...

Adidas Employees Want Company to Investigate HR Chief for Response to Racial Issues

A group of Adidas employees from around the globe is asking the company to investigate its chief human resources officer, as part of a...